Pamrevlumab (anti-CTGF)

製品コード：A2042         Batch: A204204

印刷

Pamrevlumab, a recombinant human antibody that binds to connective tissue growth factor (CTGF) has emerged as a potential therapy for idiopathic pulmonary fibrosis (IPF).

製品説明

CAS No. 946415-13-0
Formulation PBS Buffer, PH 7.4
Isotype Human IgG1, κ
Application Pamrevlumab (anti-CTGF)
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.
Shipping Shipped under low temperature conditions
Purity 99%
Protein concentration 13.176mg/ml
Endotoxin Level ＜1EU/mg

カスタマーフィードバック

A2042-Pamrevlumab-(anti-CTGF).gif

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

Microvascular Endothelial Cells License APS Vasculopathy Through YAP1- and CCN2-Mediated Signaling [ Circulation, 2025, Online ahead of print] PubMed: nan
Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer [ Cell Reports Medicine, 2025, 102480] PubMed: nan
[ Cell Commun Signal, 2024, ] PubMed: 38291510
ER stress-induced YAP upregulation leads to chondrocyte phenotype loss in age-related osteoarthritis [ Front Pharmacol, 2024, 15:1476255] PubMed: 39600372
ER stress-induced YAP upregulation leads to chondrocyte phenotype loss in age-related osteoarthritis [ Frontiers in Pharmacology, 2024, 1476255] PubMed: nan

人間や獣医の診断であるか治療的な使用のためにでない。